Skip to Content

Press Release

Tiziana Life Sci PLC - Filing of SEC Form F-3

January 23, 2020 at 2:00 AM EST
RNS Number : 6388A
Tiziana Life Sciences PLC
23 January 2020

Tiziana Life Sciences plc

("Tiziana" or the "Company")

Tiziana Life Sciences Announces F-3 Filing

New York/London, 23 January 2020 - Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS), a biotechnology company focusing on the discovery and development of innovative therapeutics for inflammation and oncology indications, announces the Company has today filed a Form F-3 with the Securities Exchange Commission. An F-3 filing is a shelf registration statement for securities which may enable the Company to potentially conduct a future fundraising (but absent any specific terms at the current time).


Tiziana Life Sciences plc

Gabriele Cerrone, Chairman and founder

+44 (0)20 7495 2379




Cairn Financial Advisers LLP (Nominated adviser)

Liam Murray / Jo Turner

+ 44 (0)20 7213 0880




Shore Capital (Broker)

Antonio Bossi / Fiona Conroy

+44 (0)20 7601 6125




Receive news and updates from Tiziana Life Sciences plc by signing up to get email alerts straight to you on https://ir.tizianalifesciences



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit